Overview
Brunner syndrome, also known as tyrosinemia type III, is a rare autosomal recessive disorder characterized by elevated levels of succinylacetone and tyrosine metabolites in the blood and urine. It primarily affects the liver and kidneys, leading to potential hepatotoxicity and renal dysfunction if not managed appropriately. The condition is typically diagnosed in childhood but can present at any age. Understanding and managing dietary restrictions, particularly regarding tyramine-rich foods, is crucial for preventing hypertensive crises and other acute complications. This matters in day-to-day practice as careful dietary counseling and monitoring are essential to prevent severe adverse events and ensure optimal patient outcomes 1.Pathophysiology
Brunner syndrome arises from mutations in the HPD gene, which encodes the trifunctional protein (HPD) involved in the catabolism of tyrosine. This genetic defect disrupts the breakdown of tyrosine and its metabolites, leading to the accumulation of succinylacetone and other toxic intermediates. At the molecular level, the impaired activity of HPD disrupts the heme synthesis pathway, affecting not only liver function but also potentially impacting renal function due to the systemic effects of these toxic metabolites. Clinically, this accumulation can manifest as liver damage, characterized by elevated liver enzymes and potential hepatomegaly, alongside renal dysfunction, which may include proteinuria and renal tubular acidosis. The variability in clinical severity often correlates with the specific mutation and the degree of enzyme deficiency 1.Epidemiology
The exact incidence and prevalence of Brunner syndrome remain poorly defined due to its rarity and variability in clinical presentation. It is predominantly observed in populations with a higher carrier frequency for the associated mutations, such as certain ethnic groups, particularly those of Finnish descent. Data suggest a carrier frequency of about 1 in 200 in Finland, indicating a higher risk of occurrence in this population compared to others. No significant sex predilection has been noted, and the condition can present at any age, though childhood onset is more commonly reported. Trends over time suggest that improved diagnostic capabilities have led to earlier identification, though large-scale epidemiological studies are lacking 1.Clinical Presentation
Patients with Brunner syndrome may present with a range of symptoms, from asymptomatic to severe hepatorenal dysfunction. Typical presentations include intermittent or persistent elevations in liver enzymes (AST, ALT), jaundice, and abdominal pain indicative of hepatotoxicity. Renal manifestations can include proteinuria, electrolyte imbalances, and signs of renal tubular acidosis. Red-flag features include acute episodes of hypertension, which can be triggered by the ingestion of tyramine-rich foods, necessitating prompt diagnostic evaluation to rule out hypertensive crises. These symptoms often prompt further investigation into metabolic disorders, leading to the diagnosis 1.Diagnosis
The diagnosis of Brunner syndrome involves a combination of clinical suspicion, biochemical markers, and genetic testing. Initial steps include assessing elevated levels of succinylacetone and tyrosine metabolites in blood and urine samples. Specific diagnostic criteria include:Differential Diagnosis
Management
First-Line Management
Second-Line Management
Refractory Cases / Specialist Escalation
Complications
Prognosis & Follow-Up
The prognosis for individuals with Brunner syndrome varies widely depending on the severity of metabolic derangements and adherence to dietary restrictions. Prognostic indicators include early diagnosis, strict dietary compliance, and regular monitoring of liver and renal function. Recommended follow-up intervals typically include:Special Populations
Key Recommendations
References
1 Shulman KI, Walker SE. Refining the MAOI diet: tyramine content of pizzas and soy products. The Journal of clinical psychiatry 1999. link